{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T08:41:59Z","timestamp":1792917719076,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004866","name":"New York State Office of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01 MH073915"],"award-info":[{"award-number":["R01 MH073915"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.biopsych.2011.06.023","type":"journal-article","created":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T15:01:56Z","timestamp":1313679716000},"page":"897-904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Serotonin 2A Receptors in Obsessive-Compulsive Disorder: A Positron Emission Tomography Study with [11C]MDL 100907"],"prefix":"10.1016","volume":"70","author":[{"given":"Helen Blair","family":"Simpson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Slifstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anissa","family":"Abi-Dargham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2011.06.023_bib1","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/scnp.2001.21833","article-title":"Brain-behavior relationships in obsessive-compulsive disorder","volume":"6","author":"Saxena","year":"2001","journal-title":"Semin Clin Neuropsychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1034\/j.1600-0447.2000.102006401.x","article-title":"On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions","volume":"102","author":"Carlsson","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2011.06.023_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nurx.2005.12.006","article-title":"Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder","volume":"3","author":"Pittenger","year":"2006","journal-title":"NeuroRx"},{"key":"10.1016\/j.biopsych.2011.06.023_bib4","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/CHI.0b013e318185d2be","article-title":"Brain imaging in pediatric obsessive-compulsive disorder","volume":"47","author":"MacMaster","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S1461145701002401","article-title":"Brain anatomy and chemistry may predict treatment response in paediatric obsessive-compulsive disorder","volume":"4","author":"Rosenberg","year":"2001","journal-title":"Int J Neuropsychopharmacol"},{"issue":"suppl","key":"10.1016\/j.biopsych.2011.06.023_bib6","first-page":"17","article-title":"The serotonin hypothesis of obsessive compulsive disorder: Implications of pharmacologic challenge studies","volume":"53","author":"Barr","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib7","series-title":"Textbook of Anxiety Disorders","first-page":"191","article-title":"Pathogenesis of obsessive-compulsive disorder","author":"Rauch","year":"2002"},{"key":"10.1016\/j.biopsych.2011.06.023_bib8","series-title":"Encyclopedia of Psychopharmacology","article-title":"PET Imaging","author":"Slifstein","year":"2010"},{"key":"10.1016\/j.biopsych.2011.06.023_bib9","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0006-3223(03)00544-4","article-title":"Serotonin transporters in obsessive-compulsive disorder: A positron emission tomography study with [(11)C]McN 5652","volume":"54","author":"Simpson","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuroimage.2009.07.069","article-title":"Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: A [11C]DASB PET study","volume":"49","author":"Matsumoto","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2011.06.023_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1096-9861(20000214)417:3<337::AID-CNE7>3.0.CO;2-O","article-title":"Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex","volume":"417","author":"Jakab","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2011.06.023_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1098-2396(199709)27:1<79::AID-SYN8>3.0.CO;2-A","article-title":"Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex","volume":"27","author":"Willins","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2011.06.023_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pnpbp.2005.11.005","article-title":"Mechanisms of action of current and potential pharmacotherapies of obsessive-compulsive disorder","volume":"30","author":"El Mansari","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2011.06.023_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.jcbfm.9600323","article-title":"Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907","volume":"27","author":"Hinz","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2011.06.023_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S1461145705005055","article-title":"Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei","volume":"8","author":"Adams","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2011.06.023_bib17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0969-8051(99)00022-0","article-title":"Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [18F]altanserin in human and rodent","volume":"26","author":"Tan","year":"1999","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.biopsych.2011.06.023_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/1098-2396(20001215)38:4<421::AID-SYN7>3.0.CO;2-X","article-title":"Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907","volume":"38","author":"Hall","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2011.06.023_bib19","doi-asserted-by":"crossref","unstructured":"Talbot PS, Slifstein M, Hwang D-R, Huang Y, Scher E, Abi-Dargham A, Laruelle M (in press): Extended characterization of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in healthy humans. NeuroImage. doi:10.1016\/j.neuroimage.2011.07.001.","DOI":"10.1016\/j.neuroimage.2011.07.001"},{"key":"10.1016\/j.biopsych.2011.06.023_bib20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archpsyc.57.7.675","article-title":"Brief screening for family psychiatric history: The family history screen","volume":"57","author":"Weissman","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib21","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition","author":"First","year":"1996"},{"key":"10.1016\/j.biopsych.2011.06.023_bib22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown Obsessive Compulsive Scale","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib23","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","article-title":"The Yale-Brown Obsessive Compulsive Scale","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib25","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.psychres.2006.09.005","article-title":"Taboo thoughts and doubt\/checking: a refinement of the factor structure for obsessive-compulsive disorder symptoms","volume":"151","author":"Pinto","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2011.06.023_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1176\/appi.ajp.2009.09020287","article-title":"Using individual items to clarify OCD symptom structure: The case for five factors","volume":"166","author":"Pinto","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.psychres.2007.07.010","article-title":"Further development of YBOCS dimensions in the OCD Collaborative Genetics study: Symptoms vs. categories","volume":"160","author":"Pinto","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2011.06.023_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0024-3205(96)00013-6","article-title":"[11C]MDL 100907, a radioligand for selective imaging of 5-HT(2A) receptors with positron emission tomography","volume":"58","author":"Lundkvist","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.biopsych.2011.06.023_bib29","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1523\/JNEUROSCI.22-09-03708.2002","article-title":"Prefrontal dopamine D1 receptors and working memory in schizophrenia","volume":"22","author":"Abi-Dargham","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2011.06.023_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00004647-200002000-00003","article-title":"Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: Validation and reproducibility","volume":"20","author":"Abi-Dargham","year":"2000","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2011.06.023_bib31","first-page":"228","article-title":"SPECT measurement of benzodiazepine receptors in human brain with iodine-123-iomazenil: kinetic and equilibrium paradigms","volume":"35","author":"Abi-Dargham","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2011.06.023_bib32","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/syn.20105","article-title":"Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans","volume":"55","author":"Talbot","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2011.06.023_bib33","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1038\/npp.2008.33","article-title":"Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride","volume":"33","author":"Kegeles","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2011.06.023_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/nimg.1997.0290","article-title":"Multimodal image coregistration and partitioning\u2014a unified framework","volume":"6","author":"Ashburner","year":"1997","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2011.06.023_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1118\/1.598130","article-title":"Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures","volume":"24","author":"Studholme","year":"1997","journal-title":"Med Phys"},{"key":"10.1016\/j.biopsych.2011.06.023_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.mibio.2003.09.009","article-title":"Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography","volume":"5","author":"Laruelle","year":"2003","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.biopsych.2011.06.023_bib37","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2011.06.023_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ana.410150302","article-title":"A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography","volume":"15","author":"Mintun","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2011.06.023_bib39","first-page":"281","article-title":"Cognitive dysfunction in obsessive-compulsive disorder","volume":"101","author":"Okasha","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2011.06.023_bib40","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.biopsych.2011.06.023_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate\u2014a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.biopsych.2011.06.023_bib42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00004583-200103000-00015","article-title":"Regional cerebral blood flow abnormalities in early-onset obsessive-compulsive disorder: An exploratory SPECT study","volume":"40","author":"Busatto","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib43","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.neubiorev.2009.01.003","article-title":"Paediatric obsessive-compulsive disorder, a neurodevelopmental disorder?","volume":"33","author":"Huyser","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2011.06.023_bib44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.biopsych.2006.09.030","article-title":"Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder","volume":"61","author":"Dickel","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib45","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/archpsyc.63.7.778","article-title":"Association testing of the positional and functional candidate gene SLC1A1\/EAAC1 in early-onset obsessive-compulsive disorder","volume":"63","author":"Dickel","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib46","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1176\/ajp.2006.163.9.1580","article-title":"Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: A positron emission study with [(11)C]MDL 100,907","volume":"163","author":"Bhagwagar","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2011.06.023_bib47","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/appi.ajp.160.1.90","article-title":"Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm","volume":"160","author":"Meyer","year":"2003","journal-title":"Am J Psychiatry"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322311006688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322311006688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T14:56:09Z","timestamp":1757775369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322311006688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0006322311006688"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2011.06.023","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serotonin 2A Receptors in Obsessive-Compulsive Disorder: A Positron Emission Tomography Study with [11C]MDL 100907","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2011.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}